Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation

Circulation - United States
doi 10.1161/circulationaha.113.005376
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2013English

Satisfaction With Oral Anticoagulants in Patients With Atrial Fibrillation

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2018English

New Anticoagulants for Atrial Fibrillation

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2009English

Cost-Effectiveness of New Oral Anticoagulants for Patients With Atrial Fibrillation – A Decision Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2007English

Galectin-3 in Patients With Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation

PLoS ONE
Multidisciplinary
2015English

The Use of Novel Oral Anticoagulants in Atrial Fibrillation

Cardiovascular and Hematological Disorders - Drug Targets
Molecular MedicinePharmacologyCardiologyHematologyCardiovascular MedicineMedicine
2015English

Hybrid Atrial Fibrillation Ablation in Patients With Persistent Atrial Fibrillation or Failed Catheter Ablation

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2019English

The New Era of Atrial Fibrillation Treated by Direct Oral Anticoagulants and Catheter Ablation—Comment on the “HAF‐NET Registry”

Journal of Arrhythmia
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy